#102 - RED-S: Wenn dein Körper zu wenig Energie bekommt | Timo Tekolf – Adon Health
GDPR-compliant data management
ISO-certified laboratory
Hospital laboratory quality
Discreet ordering & shipping
Therapy based on the latest science
#102 - RED-S: Wenn dein Körper zu wenig Energie bekommt | Timo Tekolf bei Männergesundheit
< 1 Minute Lesezeit |

#102 - RED-S: Wenn dein Körper zu wenig Energie bekommt | Timo Tekolf bei Männergesundheit

Dr. Jonathan Apasu

Testosteron Experte von Adon Health

Sportwissenschaftler, Personal Trainer und Health Coach Timo Tekolf spricht über ein Thema, das viele ambitionierte Männer betrifft, ohne es zu merken: RED-S, das Relative Energy Deficiency in Sport. Was passiert, wenn Training, Stress und Alltag mehr Energie verlangen, als der Körper bekommt? In dieser Episode erfährst du, warum chronisches Kaloriendefizit nicht nur die Performance senkt, sondern auch Hormone, Regeneration, Immunsystem und Knochengesundheit massiv beeinflussen kann.  

Themen dieser Episode:

  • RED-S erklärt: Wenn der Körper dauerhaft zu wenig Energie bekommt
  • Warum auch Männer betroffen sind – nicht nur Leistungssportlerinnen
  • Testosteronmangel, Libidoverlust & Müdigkeit: Warnsignale richtig deuten
  • Hyrox, CrossFit & Hybrid Training: Warum moderne Sporttrends das Risiko erhöhen
  • Kalorientracking, Blutwerte & Selbstanalyse: So erkennst du ein Energiedefizit
  • Warum mehr Essen manchmal der Schlüssel zu besserer Performance ist

Wenn du viel trainierst, aber dich müde, antriebslos oder hormonell aus dem Gleichgewicht fühlst, solltest du diese Folge unbedingt hören! 

Links zum Podcast

Spotify Apple Music YouTube

Zusammenhängende Posts

#79 - Die Wahrheit über TRT, Peptide & Co. - Adon Health Arzt packt aus | Dr. Regaluto bei Männergesundheit

#79 - The truth about TRT, peptides & co. - Adon Health doctor speaks out | Dr. Regaluto on men's health

In this episode of "Men's Health with Dr. Jonathan Apasu," Dr. Apasu speaks with Dr. Christoph Regalbuto , internist and one of Adon Health's first partner physicians, about modern testosterone replacement therapy (TRT) . Dr. Regalbuto has already treated several hundred men with sometimes severe testosterone deficiency – from exhausted family men to athletic men in their mid-30s who, despite exercise, diet, and sleep, are persistently lethargic, irritable, or weak. A central topic of the conversation is a large study of 133,000 patients , which impressively demonstrates that correctly adjusted TRT not only improves symptoms such as exhaustion, loss of libido, and mental fatigue, but also reduces the risk of heart attack, stroke, atrial fibrillation, prostate cancer , and even overall mortality . The two discuss why this data, while clear, is often slow to be adopted in the medical field—and why many men have unnecessary fears about prostate cancer or heart problems due to misinformation or outdated ideas. Another important point: Many doctors still believe that testosterone deficiency only affects overweight, inactive men. Dr. Regalbuto explains, however, that fit, young men are also frequently affected – and are not taken seriously in traditional practices. This is precisely where modern, evidence-based diagnostics and treatment come into play. The episode clearly distinguishes between medically supervised TRT and steroid abuse ("drugs") in bodybuilding . It explains why the risks often attributed to testosterone in the media stem almost exclusively from supraphysiological scenarios and have nothing to do with reputable TRT. Instead, the therapy focuses on finding a patient's individual "sweet spot" where vitality, mood, and libido are stable and side effects remain controlled. Another focus is the topic of fertility . The two explain why a current desire to have children is a clear contraindication for TRT and what alternatives exist—such as clomiphene, tamoxifen, hCG, or recombinant FSH —to support sperm production. At the same time, the fear of "lifelong dependence" is dispelled: studies show that both the body's own testosterone production and sperm production usually normalize within 9–12 months after discontinuing TRT. Finally, Dr. Regalbuto and Dr. Apasu address a trending topic: peptides such as BPC-157 and TB-500. They explain why animal studies are promising, but why there are hardly any human studies and no approved preparations – and why caution is advised despite potential benefits. This episode provides one of the most comprehensive German-language insights into the topics of testosterone deficiency, TRT, hormone health, heart and prostate risks, fertility, steroid abuse, and peptide therapy . Any man concerned about his long-term health or experiencing symptoms of testosterone deficiency will find well-founded, understandable, and scientifically proven answers here.

Learn more
#76 - Testosteron im Wettkampf: Was ist erlaubt? | NADA-Expertinnen Dr. Eva Bunthoff & Jutta Müller-Reul bei Männergesundheit

#76 - Testosterone in competition: What's allowed? | NADA experts Dr. Eva Bunthoff & Jutta Müller-Reul at Men's Health

In sports, testosterone replacement therapy is generally considered doping, even if medically prescribed. Testosterone may only be used legally with a valid Therapeutic Use Exemption (TUE). A TUE is a medical exemption that allows athletes to use a normally prohibited substance when it is medically necessary and no alternative treatment is available. In Germany, applications for a Therapeutic Use Exemption (TUE) are submitted to the National Anti-Doping Agency (NADA). There, the case is reviewed medically and according to regulations. After completion of the process, the result is forwarded to the World Anti-Doping Agency (WADA). WADA verifies whether the decision complies with the worldwide Anti-Doping Code. WADA thus assumes an important compliance function. It ensures that Therapeutic Use Exemptions (TUEs) are assessed internationally according to the same criteria and that no national differences or special regulations arise. Particularly with sensitive substances like testosterone, it is rigorously checked whether each TUE is correctly justified, medically warranted, and approved in accordance with regulations. WADA can also revoke TUEs retroactively if they were not issued in accordance with the rules. This is intended to prevent national agencies from being too lenient or athletes from receiving unjustified advantages. The goal is the global harmonization of rules and the assurance of fairness and equal opportunities in competitive sports. In the new episode of the Men's Health Podcast, Dr. Jonathan Apasu speaks with Dr. Eva Bunthoff, board member of NADA, and Jutta Müller-Reul from the medical field about testosterone, doping controls, TUEs, and the role of WADA. The two experts provide insights into medical and sports law practices and explain how responsible testosterone therapy, health, and fairness in competitive sports are interconnected. Listen now and find out how NADA and WADA work together, what criteria must be met for a TUE, and why transparency and clear rules are crucial for the integrity of sport.

Learn more
#87 - Prostatakrebs & Hodenkrebs: Was Männer wissen müssen | Prof. Axel Heidenreich bei Männergesundheit

#87 - Prostate Cancer & Testicular Cancer: What Men Need to Know | Prof. Axel Heidenreich at Men's Health

Prostate and testicular cancer are among the most important, yet most misunderstood, cancers in men. In this in-depth episode of the men's health podcast, Dr. Jonathan Apasu speaks with Prof. Dr. Axel Heidenreich , one of Europe's leading urologists, about the causes, prevention, modern diagnostics, and contemporary treatment approaches for urological tumors. Why does testicular cancer often affect very young men? Is prostate cancer always aggressive? When is observation sufficient, and when is surgery or radiation necessary? Professor Heidenreich explains clearly why early detection saves lives, why the PSA test is evaluated differently today than in the past, and why many men have unnecessary fears about preventative care. Topics in this episode: Testicular cancer in young men: causes, prognosis & chances of recovery Prostate cancer: Frequency, aggressiveness and modern risk assessment PSA testing & preventative care from age 45: What really makes sense Modern diagnostics: MRI, targeted biopsies & pathology Active Surveillance vs. Surgery vs. Radiation Potency, continence & quality of life after therapy Hormone withdrawal, side effects & long-term consequences Why second opinions can save lives This episode is aimed at men of all ages: informative and evidence-based. You can find more information about Prof. Dr. Dr. Axel Heidenreich on the website of the Urology Department of the University Hospital of Cologne here .

Learn more